Cosmos Health (COSM, $5.33) updates letter of intent to acquire ZipDoctor
Cosmos Health Inc. announced that it has revised a non-binding letter of intent to buy telemedicine business ZipDoctor Inc. The healthcare company said it renegotiated the price "to achieve much improved payment terms."
The updated letter will remain effective until February 15, 2023.
ZipDoctor is a wholly owned subsidiary of American International Holdings Corp., and is a direct-to-consumer subscription-based telemedicine platform.
Greg Siokas, Chief Executive Officer of Cosmos Health said in a statement, "We are enthusiastic about the proposed addition of ZipDoctor to Cosmos Heath's family of companies. The telehealth industry is set for strong growth, and we believe that ZipDoctor, with the proper investment from Cosmos, can become a significant player in the space. Furthermore, we intend to expand on ZipDoctor's current primary care and mental health service offerings to include the ability to speak to a doctor to seek additional medical treatments related to and including men's and women's health and wellness issues, weight loss and other similar treatments. Furthermore, we are satisfied with the renegotiated price of the acquisition, as we are always looking to increase our returns on investment."
COSM's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for COSM turned positive on August 21, 2026. Looking at past instances where COSM's MACD turned positive, the stock continued to rise in 40 of 43 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on August 26, 2026. You may want to consider a long position or call options on COSM as a result. In 82 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
COSM moved above its 50-day moving average on August 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for COSM crossed bullishly above the 50-day moving average on September 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
Following a +14.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where COSM advanced for three days, in 185 of 213 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
The Aroon Indicator entered an Uptrend today. In 46 of 53 cases where COSM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where COSM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
COSM broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. COSM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.547) is normal, around the industry mean (2.499). COSM has a moderately high P/E Ratio (94.580) as compared to the industry average of (39.156). Projected Growth (PEG Ratio) (0.850) is also within normal values, averaging (2.022). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (0.160) is also within normal values, averaging (4.260).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COSM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry MedicalDistributors
Advertisement